Aspire Private Capital’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,345
Closed -$25.8K 218
2024
Q3
$25.8K Hold
1,345
0.01% 285
2024
Q2
$26.8K Sell
1,345
-489
-27% -$9.17K 0.01% 289
2024
Q1
$35.6K Buy
1,834
+32
+2% +$574 0.01% 262
2023
Q4
$30.1K Buy
1,802
+34
+2% +$550 0.01% 265
2023
Q3
$29.2K Buy
1,768
+48
+3% +$848 0.01% 271
2023
Q2
$31.2K Buy
1,720
+47
+3% +$809 0.01% 251
2023
Q1
$31.3K Buy
1,673
+51
+3% +$895 0.01% 249
2022
Q4
$25.4K Buy
1,622
+55
+4% +$935 0.01% 259
2022
Q3
$28K Buy
1,567
+45
+3% +$927 0.01% 250
2022
Q2
$30K Buy
1,522
+39
+3% +$914 0.01% 243
2022
Q1
$44K Buy
1,483
+30
+2% +$895 0.01% 218
2021
Q4
$57K Buy
1,453
+60
+4% +$2.39K 0.02% 210
2021
Q3
$54K Buy
1,393
+18
+1% +$730 0.02% 207
2021
Q2
$57K Buy
1,375
+18
+1% +$682 0.02% 205
2021
Q1
$48K Buy
+1,357
New +$49.4K 0.02% 223

Other funds holding BSTZ

Aspire Private Capital's BSTZ Position: Q4 2024 in Review

Aspire Private Capital sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q4 2024, closing a stake of 1,345 shares — an estimated $25.8K sold.

Aspire Private Capital first reported a position in BSTZ in Q1 2021 and held it in 15 quarters. The position peaked at $57K in Q4 2021. 110 funds tracked by Wall St. Rank hold BSTZ as of Q4 2024.

  • Aspire Private Capital reported no remaining BlackRock Science and Technology Term Trust position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 1,345 BlackRock Science and Technology Term Trust shares in Q4 2024, an estimated $25.8K.
  • Aspire Private Capital first reported a position in BlackRock Science and Technology Term Trust in Q1 2021 and held it in 15 quarters.
  • Aspire Private Capital's BlackRock Science and Technology Term Trust position peaked at $57K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.